BIOMAT Database Logo BIOMAT Database Logo

Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling. 2012

Karen E Deffenbacher, and Javeed Iqbal, and Warren Sanger, and Yulei Shen, and Cynthia Lachel, and Zhongfeng Liu, and Yanyan Liu, and Megan S Lim, and Sherrie L Perkins, and Kai Fu, and Lynette Smith, and James Lynch, and Louis M Staudt, and Lisa M Rimsza, and Elaine Jaffe, and Andreas Rosenwald, and German K Ott, and Jan Delabie, and Elias Campo, and Randy D Gascoyne, and Mitchell S Cairo, and Dennis D Weisenburger, and Timothy C Greiner, and Thomas G Gross, and Wing C Chan
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, 68198-3135, USA.

Burkitt lymphoma (BL) predominates in pediatric patients, whereas diffuse large B-cell lymphoma (DLBCL) is uncommon. In contrast to adults, BL and DLBCL are treated similarly in children and both entities have superior outcomes in children compared with adults. Gene expression profiling (GEP) and miRNA expression profiling clearly differentiated pediatric DLBCL from BL, forming distinct clusters regardless of patient age. However, pathway analysis of GEP data identified minor differences between corresponding pediatric and adult tumors. Predominance (6:1) of the germinal center B-cell subtype to activated B-cell subtype was found among pediatric DLBCL. Two cases were molecularly classified as primary mediastinal B-cell lymphoma. We observed frequent abnormalities in 8q24 in pediatric DLBCL, including MYC rearrangement in 31% (5 of 16) and gain or amplification in 50% (6 of 12) nonrearranged cases. MYC rearrangement was present in 96% (23 of 24) BL cases. Array-based CGH analysis identified abnormalities that are shared between adult and pediatric DLBCL (+12q15, +19q13, -6q), and abnormalities unique to the pediatric cases (-4p14, -19q13.32, +16p11.2), suggesting distinct pathogenetic mechanisms relative to age. Elucidation of the underlying target genes may provide insight into factors that modulate outcome and could provide potential novel therapeutic targets with less toxicity for pediatric patients with B-cell non-Hodgkin lymphoma.

UI MeSH Term Description Entries
D008228 Lymphoma, Non-Hodgkin Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease. Non-Hodgkin Lymphoma,Diffuse Mixed Small and Large Cell Lymphoma,Diffuse Mixed-Cell Lymphoma,Diffuse Small Cleaved-Cell Lymphoma,Diffuse Undifferentiated Lymphoma,Lymphatic Sarcoma,Lymphoma, Atypical Diffuse Small Lymphoid,Lymphoma, Diffuse,Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic,Lymphoma, High-Grade,Lymphoma, Intermediate-Grade,Lymphoma, Low-Grade,Lymphoma, Mixed,Lymphoma, Mixed Cell, Diffuse,Lymphoma, Mixed Lymphocytic-Histiocytic,Lymphoma, Mixed Small and Large Cell, Diffuse,Lymphoma, Mixed-Cell,Lymphoma, Mixed-Cell, Diffuse,Lymphoma, Non-Hodgkin's,Lymphoma, Non-Hodgkin, Familial,Lymphoma, Non-Hodgkins,Lymphoma, Nonhodgkin's,Lymphoma, Nonhodgkins,Lymphoma, Pleomorphic,Lymphoma, Small Cleaved Cell, Diffuse,Lymphoma, Small Cleaved-Cell, Diffuse,Lymphoma, Small Non-Cleaved-Cell,Lymphoma, Small Noncleaved-Cell,Lymphoma, Small and Large Cleaved-Cell, Diffuse,Lymphoma, Undifferentiated,Lymphoma, Undifferentiated, Diffuse,Lymphosarcoma,Mixed Small and Large Cell Lymphoma, Diffuse,Mixed-Cell Lymphoma,Mixed-Cell Lymphoma, Diffuse,Non-Hodgkin's Lymphoma,Reticulosarcoma,Reticulum Cell Sarcoma,Reticulum-Cell Sarcoma,Sarcoma, Lymphatic,Sarcoma, Reticulum-Cell,Small Cleaved-Cell Lymphoma, Diffuse,Small Non-Cleaved-Cell Lymphoma,Small Noncleaved-Cell Lymphoma,Undifferentiated Lymphoma,Diffuse Lymphoma,Diffuse Lymphomas,Diffuse Mixed Cell Lymphoma,Diffuse Mixed-Cell Lymphomas,Diffuse Small Cleaved Cell Lymphoma,Diffuse Undifferentiated Lymphomas,High-Grade Lymphoma,High-Grade Lymphomas,Intermediate-Grade Lymphoma,Intermediate-Grade Lymphomas,Low-Grade Lymphoma,Low-Grade Lymphomas,Lymphatic Sarcomas,Lymphocytic-Histiocytic Lymphoma, Mixed,Lymphocytic-Histiocytic Lymphomas, Mixed,Lymphoma, Diffuse Mixed-Cell,Lymphoma, Diffuse Undifferentiated,Lymphoma, High Grade,Lymphoma, Intermediate Grade,Lymphoma, Low Grade,Lymphoma, Mixed Cell,Lymphoma, Mixed Lymphocytic Histiocytic,Lymphoma, Non Hodgkin,Lymphoma, Non Hodgkin's,Lymphoma, Non Hodgkins,Lymphoma, Nonhodgkin,Lymphoma, Small Non Cleaved Cell,Lymphoma, Small Noncleaved Cell,Lymphosarcomas,Mixed Cell Lymphoma,Mixed Cell Lymphoma, Diffuse,Mixed Lymphocytic-Histiocytic Lymphoma,Mixed Lymphocytic-Histiocytic Lymphomas,Mixed Lymphoma,Mixed Lymphomas,Mixed-Cell Lymphomas,Non Hodgkin Lymphoma,Non Hodgkin's Lymphoma,Non-Cleaved-Cell Lymphoma, Small,Non-Hodgkins Lymphoma,Noncleaved-Cell Lymphoma, Small,Nonhodgkin's Lymphoma,Nonhodgkins Lymphoma,Pleomorphic Lymphoma,Pleomorphic Lymphomas,Reticulosarcomas,Reticulum Cell Sarcomas,Reticulum-Cell Sarcomas,Sarcoma, Reticulum Cell,Small Cleaved Cell Lymphoma, Diffuse,Small Non Cleaved Cell Lymphoma,Small Non-Cleaved-Cell Lymphomas,Small Noncleaved Cell Lymphoma,Small Noncleaved-Cell Lymphomas,Undifferentiated Lymphoma, Diffuse,Undifferentiated Lymphomas
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002051 Burkitt Lymphoma A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. African Lymphoma,Burkitt Cell Leukemia,Burkitt Tumor,Lymphoma, Burkitt,Burkitt Leukemia,Burkitt's Leukemia,Burkitt's Lymphoma,Burkitt's Tumor,Leukemia, Lymphoblastic, Burkitt-Type,Leukemia, Lymphocytic, L3,Lymphocytic Leukemia, L3,Burkitts Leukemia,Burkitts Lymphoma,Burkitts Tumor,L3 Lymphocytic Leukemia,L3 Lymphocytic Leukemias,Leukemia, Burkitt,Leukemia, Burkitt Cell,Leukemia, Burkitt's,Leukemia, L3 Lymphocytic,Lymphoma, African,Lymphoma, Burkitt's,Tumor, Burkitt,Tumor, Burkitt's
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Karen E Deffenbacher, and Javeed Iqbal, and Warren Sanger, and Yulei Shen, and Cynthia Lachel, and Zhongfeng Liu, and Yanyan Liu, and Megan S Lim, and Sherrie L Perkins, and Kai Fu, and Lynette Smith, and James Lynch, and Louis M Staudt, and Lisa M Rimsza, and Elaine Jaffe, and Andreas Rosenwald, and German K Ott, and Jan Delabie, and Elias Campo, and Randy D Gascoyne, and Mitchell S Cairo, and Dennis D Weisenburger, and Timothy C Greiner, and Thomas G Gross, and Wing C Chan
Apoptotic Blocks in Primary Non-Hodgkin B Cell Lymphomas Identified by BH3 Profiling.
February 2021, Cancers,
Karen E Deffenbacher, and Javeed Iqbal, and Warren Sanger, and Yulei Shen, and Cynthia Lachel, and Zhongfeng Liu, and Yanyan Liu, and Megan S Lim, and Sherrie L Perkins, and Kai Fu, and Lynette Smith, and James Lynch, and Louis M Staudt, and Lisa M Rimsza, and Elaine Jaffe, and Andreas Rosenwald, and German K Ott, and Jan Delabie, and Elias Campo, and Randy D Gascoyne, and Mitchell S Cairo, and Dennis D Weisenburger, and Timothy C Greiner, and Thomas G Gross, and Wing C Chan
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
February 2017, Blood,
Karen E Deffenbacher, and Javeed Iqbal, and Warren Sanger, and Yulei Shen, and Cynthia Lachel, and Zhongfeng Liu, and Yanyan Liu, and Megan S Lim, and Sherrie L Perkins, and Kai Fu, and Lynette Smith, and James Lynch, and Louis M Staudt, and Lisa M Rimsza, and Elaine Jaffe, and Andreas Rosenwald, and German K Ott, and Jan Delabie, and Elias Campo, and Randy D Gascoyne, and Mitchell S Cairo, and Dennis D Weisenburger, and Timothy C Greiner, and Thomas G Gross, and Wing C Chan
Genomic landscape of mature B-cell non-Hodgkin lymphomas - an appraisal from lymphomagenesis to drug resistance.
December 2022, Journal of the Egyptian National Cancer Institute,
Karen E Deffenbacher, and Javeed Iqbal, and Warren Sanger, and Yulei Shen, and Cynthia Lachel, and Zhongfeng Liu, and Yanyan Liu, and Megan S Lim, and Sherrie L Perkins, and Kai Fu, and Lynette Smith, and James Lynch, and Louis M Staudt, and Lisa M Rimsza, and Elaine Jaffe, and Andreas Rosenwald, and German K Ott, and Jan Delabie, and Elias Campo, and Randy D Gascoyne, and Mitchell S Cairo, and Dennis D Weisenburger, and Timothy C Greiner, and Thomas G Gross, and Wing C Chan
Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas.
January 2019, Frontiers in oncology,
Karen E Deffenbacher, and Javeed Iqbal, and Warren Sanger, and Yulei Shen, and Cynthia Lachel, and Zhongfeng Liu, and Yanyan Liu, and Megan S Lim, and Sherrie L Perkins, and Kai Fu, and Lynette Smith, and James Lynch, and Louis M Staudt, and Lisa M Rimsza, and Elaine Jaffe, and Andreas Rosenwald, and German K Ott, and Jan Delabie, and Elias Campo, and Randy D Gascoyne, and Mitchell S Cairo, and Dennis D Weisenburger, and Timothy C Greiner, and Thomas G Gross, and Wing C Chan
MYD88 expression and L265P mutation in mature B-cell non-Hodgkin lymphomas.
July 2015, Genetic testing and molecular biomarkers,
Karen E Deffenbacher, and Javeed Iqbal, and Warren Sanger, and Yulei Shen, and Cynthia Lachel, and Zhongfeng Liu, and Yanyan Liu, and Megan S Lim, and Sherrie L Perkins, and Kai Fu, and Lynette Smith, and James Lynch, and Louis M Staudt, and Lisa M Rimsza, and Elaine Jaffe, and Andreas Rosenwald, and German K Ott, and Jan Delabie, and Elias Campo, and Randy D Gascoyne, and Mitchell S Cairo, and Dennis D Weisenburger, and Timothy C Greiner, and Thomas G Gross, and Wing C Chan
B-cell non-Hodgkin lymphomas.
May 2024, Lancet (London, England),
Karen E Deffenbacher, and Javeed Iqbal, and Warren Sanger, and Yulei Shen, and Cynthia Lachel, and Zhongfeng Liu, and Yanyan Liu, and Megan S Lim, and Sherrie L Perkins, and Kai Fu, and Lynette Smith, and James Lynch, and Louis M Staudt, and Lisa M Rimsza, and Elaine Jaffe, and Andreas Rosenwald, and German K Ott, and Jan Delabie, and Elias Campo, and Randy D Gascoyne, and Mitchell S Cairo, and Dennis D Weisenburger, and Timothy C Greiner, and Thomas G Gross, and Wing C Chan
Non-Hodgkin Lymphomas: Malignancies Arising from Mature B Cells.
March 2021, Cold Spring Harbor perspectives in medicine,
Karen E Deffenbacher, and Javeed Iqbal, and Warren Sanger, and Yulei Shen, and Cynthia Lachel, and Zhongfeng Liu, and Yanyan Liu, and Megan S Lim, and Sherrie L Perkins, and Kai Fu, and Lynette Smith, and James Lynch, and Louis M Staudt, and Lisa M Rimsza, and Elaine Jaffe, and Andreas Rosenwald, and German K Ott, and Jan Delabie, and Elias Campo, and Randy D Gascoyne, and Mitchell S Cairo, and Dennis D Weisenburger, and Timothy C Greiner, and Thomas G Gross, and Wing C Chan
Global phosphoproteomic profiling reveals distinct signatures in B-cell non-Hodgkin lymphomas.
May 2014, The American journal of pathology,
Karen E Deffenbacher, and Javeed Iqbal, and Warren Sanger, and Yulei Shen, and Cynthia Lachel, and Zhongfeng Liu, and Yanyan Liu, and Megan S Lim, and Sherrie L Perkins, and Kai Fu, and Lynette Smith, and James Lynch, and Louis M Staudt, and Lisa M Rimsza, and Elaine Jaffe, and Andreas Rosenwald, and German K Ott, and Jan Delabie, and Elias Campo, and Randy D Gascoyne, and Mitchell S Cairo, and Dennis D Weisenburger, and Timothy C Greiner, and Thomas G Gross, and Wing C Chan
Proteomic profiling of mature CD10+ B-cell lymphomas.
December 2005, American journal of clinical pathology,
Karen E Deffenbacher, and Javeed Iqbal, and Warren Sanger, and Yulei Shen, and Cynthia Lachel, and Zhongfeng Liu, and Yanyan Liu, and Megan S Lim, and Sherrie L Perkins, and Kai Fu, and Lynette Smith, and James Lynch, and Louis M Staudt, and Lisa M Rimsza, and Elaine Jaffe, and Andreas Rosenwald, and German K Ott, and Jan Delabie, and Elias Campo, and Randy D Gascoyne, and Mitchell S Cairo, and Dennis D Weisenburger, and Timothy C Greiner, and Thomas G Gross, and Wing C Chan
[Pediatric non-Hodgkin lymphomas].
December 2004, Annales de pathologie,
Copied contents to your clipboard!